BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

LCA-Vision Reports Second Quarter 2013 Procedure Volume


7/2/2013 6:56:09 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CINCINNATI, July 2, 2013 /PRNewswire/ -- LCA-Vision Inc. (NASDAQ: LCAV), a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 12,994 procedures were performed during the second quarter of 2013, compared with 14,415 procedures performed during the second quarter of 2012.

"We primarily attribute the decline in procedure volume to the lowering of the maximum contribution for flexible spending accounts under the federal Patient Protection & Affordable Care Act," said LCA-Vision Chief Executive Officer Michael J. Celebrezze. "A survey of previous LasikPlus® patients conducted earlier this year showed that the contribution limit, which took effect at the beginning of 2013, is putting approximately 10% of prospective LasikPlus® patients at risk for not moving forward with the procedure. We expect that the contribution limit for flexible spending accounts will have a comparable percentage impact on procedure volume throughout the current year."

LCA-Vision will release second quarter 2013 financial results prior to the market open on Tuesday, July 30, 2013 with a conference call and webcast to follow at 10:00 a.m. Eastern time.

To access the conference call, dial 866-322-1352 (within the United States and Canada) or 706-643-6246 (international callers). The webcast will be available at the investor relations section of LCA-Vision's website. A replay of the call and webcast will begin approximately two hours after the live call has ended. To access the replay, dial 855-859-2056 (within the United States and Canada) or 404-537-3406 (international callers) and enter the conference ID number: 10544407.

About LCA-Vision Inc./LasikPlus®
LCA-Vision Inc., a leading provider of laser vision correction services, owns and operates 58 LasikPlus® vision centers in the United States: 51 full-service LasikPlus® fixed-site laser vision correction centers and seven pre- and post-operative LasikPlus® satellite centers.

For Additional Information




Company Contact:

Investor Relations Contact:

Barb Kise, LCA-Vision

Jody Cain, LHA

513-792-9292

310-691-7100


@LHA_IR_PR

SOURCE LCA-Vision Inc.



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES